Seroprevalence of hepatitis B virus markers in individuals for physical examination in West China Hospital, China

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 6, 2011, Pages 592-596

  Wang, Y B ^a,b   Chen, E Q ^a,b   Cui, Y L ^a,b   Zeng, L ^a   Wang, You Juan ^a   Tang, Hong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Health examined individuals; Hepatitis B; Prevalence; Risk factors

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHINA; CHRONIC HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; SEROPREVALENCE; VACCINATION; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ALCOHOL DRINKING; CHINA; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 79960349274     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. CHEN CC, YEN CH, WU WY, HU SW, CHEN SC, BELL WR, LEE MC. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J (Engl) 2007; 120: 1155-1158.
2. PAPATHEODORIDIS GV, MANOLAKOPOULOS S. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy. J Hepatol 2009; 51: 226-227.
3. CUSTER B, SULLIVAN SD, HAZLET TK, ILOEJE U, VEENSTRA DL, KOWDLEY KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38: S158-168.
4. ORGANIZATION WH. Hepatitis B vaccines: WHO position paper - recommendations. Vaccine 2010; 28: 589-590.
5. SUN Z, MING L, ZHU X, LU J. Prevention and control of hepatitis B in China. J Med Virol 2002; 67: 447-450.
6. JIA JD, ZHUANG H. The overview of the seminar on chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2004; 12: 698-699.
7. LIANG X, BI S, YANG W, WANG L, CUI G, CUI F, ZHANG Y, LIU J, GONG X, CHEN Y, WANG F, ZHENG H, GUO J, JIA Z, MA J, WANG H, LUO H, LI L, JIN S, HADLER SC, WANG Y. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550-6557.
8. SHULER CM, FIORE AE, NEEMAN R, BELL BP, KUHNERT W, WATKINS S, KILGOUR K, ARNOLD KE. Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents - benefit of universal infant hepatitis B vaccination. Vaccine 2009; 27: 5942-5947.
9. PAPAEVANGELOU V, HADJICHRISTODOULOU C, CASSIMOS DC, PANTELAKI K, TZIVARAS A, HATZIMICHAEL A, THEODORIDOU M. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination. Infection 2008; 36: 135-139.
10. HSU HM, LU CF, LEE SC, LIN SR, CHEN DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999; 179: 367-370.
11. GERMAN V, GIANNAKOS G, KOPTERIDES P, LIASKONIS K, FALAGAS ME. Serologic indices of hepatitis B virus infection in military recruits in Greece (2004-2005). BMC Infect Dis 2006; 6: 163.
12. TESSEMA B, YISMAW G; KASSU A, AMSALU A, MULU A, EMMRICH F, SACK U. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis 2010; 10: 111.
13. VALWAY S, JENISON S, KELLER N, VEGA-HERNANDEZ J, HUBBARD MCCREE D. Risk assessment and screening for sexually transmitted infections, HIV, and hepatitis virus among long-distance truck drivers in New Mexico, 2004-2006. Am J Public Health 2009; 99: 2063-2068.
14. LU J, ZHOU Y, LIN X, JIANG Y, TIAN R, ZHANG Y, WU J, ZHANG F, WANG Y, BI S. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007. PLoS ONE 2009; 4: e8467.
15. CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION. Result of seroepidemiological survey of hepatitis B in Chinese population [Z/OL] 2008, http://www.chinacdc.net.cn/n272442/n272530/n3246177/23316-html
16. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). The Adult Hepatitis Vaccine Project - California, 2007-2008. MMWR Morb Mortal Wkly Rep 2010; 59: 514-516.
17. WANG CS, CHANG TT, YAO WJ, CHOU P. Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study. Am J Trop Med Hyg 2002; 66: 389-393.
18. GOGOS CA, FOUKA KP, NIKIFORIDIS G, AVGERIDIS K, SAKELLAROPOULOS G, BASSARIS H, MANIATIS A SKOUTEUS A. Prevalence of hepatitis B and C virus infection in the general population and selected groups in Southwestern Greece. Eur J Epidemiol 2003; 18: 551-557.
19. MOTA A, GUEDES F, AREIAS J, PINHO L, CARDOSO MF. Alcohol consumption among patients with hepatitis B infection in northern Portugal considering gender and hepatitis B virus genotype differences. Alcohol 2010; 44: 149-156.
20. MEHEUS A. Teenagers' lifestyle and the risk of exposure to hepatitis B virus. Vaccine 2000; 18: S26-29.